Insider Trading & Ownership - Balthaser Kevin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Balthaser Kevin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-06
Purchase
2023-09-07
4:16 pm
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
9,490$7.9$74,97115,461
(Direct)
View
2023-03-02
Sale
2023-03-03
8:09 pm
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
1,894$12.45$23,57916,081
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-01
Exercise
2024-09-04
7:52 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
1,000$024,697
(Direct)
View
2024-09-01
Tax Withholding
2024-09-04
7:52 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
286$1.1824,697
(Direct)
View
2024-03-01
Exercise
2024-03-05
5:02 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
4,975$029,833
(Direct)
View
2024-03-01
Tax Withholding
2024-03-05
5:02 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
1,417$1.2429,833
(Direct)
View
2024-02-01
Option Award
2024-02-05
7:27 pm
N/A
2034-01-31
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
413,000$0413,000
(Direct)
View
2024-01-01
Exercise
2024-01-03
4:47 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
7,500$042,925
(Direct)
View
2024-01-01
Tax Withholding
2024-01-03
4:47 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
2,536$1.0542,925
(Direct)
View
2023-09-01
Exercise
2023-09-05
5:08 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
1,000$06,971
(Direct)
View
2023-09-01
Tax Withholding
2023-09-05
5:08 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
285$7.96,971
(Direct)
View
2023-03-01
Exercise
2023-03-03
8:09 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
6,450$016,081
(Direct)
View
2023-02-01
Option Award
2023-02-03
4:55 pm
N/A
2033-01-31
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
135,000$0135,000
(Direct)
View

Ownership
2023-01-06
4:31 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSBalthaser Kevin
Chief Financial Officer
0$082,175
(Direct)
View